Latest Breaking News On - Professor philip beales - Page 1 : comparemela.com

Renowned Geneticist Philip Beales Launches Axovia Therapeutics to Develop Transformative Medicines for Ciliopathies Axovia is a majority-owned subsidiary of Jaguar Gene Therapy, which is backed by Deerfield Management LONDON, Feb. 25, 2021an innovative gene therapy company developing disease-transformative medicines for ciliopathies, led by renowned researcher Professor Philip Beales, launched today after being in stealth mode for the past year. Axovia is a majority-owned subsidiary of Jaguar Gene Therapy, which is backed by Deerfield Management, and is also partially funded by UCL Technology Fund. Axovia is receiving initial operational support from Jaguar Gene Therapy, including critical manufacturing guidance intended to expedite Axovia s development timelines and enable it to bring its much-needed discoveries to patients.

United kingdomCity ofJoe nolanKostenloser wertpapierhandelTanya nelsonPhilip bealesVictor hernandezTechnology fundJaguar gene therapyGenomic medicine at university college londonDeerfield management companyLecturer in biomedical sciences at brunel universityProfessor philip bealesDeerfield managementGenomic medicineUniversity college london